Provided By GlobeNewswire
Last update: Jun 24, 2025
BROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the upcoming State of Spine Surgery Think Tank, taking place in Cabo San Lucas, June 25-28, 2025.
Read more at globenewswire.com0.075
+0.04 (+94.3%)
6.945
+0.37 (+5.55%)
Find more stocks in the Stock Screener


